Characteristics | Descriptive statistics | C group | F group | Df | P Value |
---|---|---|---|---|---|
Case number | n | 120 | 32 | Â | Â |
Age | Mean ± SD | 51.89 ± 10.96 | 56.47 ± 11.36 | 150 | 0.039a |
 | Range | 22–79 | 31–81 | ||
Gender | Â | Â | Â | 1 | 0.844c |
 Male | n (%) | 92 (76.7%) | 24 (75.0%) | ||
 Female | n (%) | 28 (23.3%) | 8 (25.0%) | ||
Period of pain (months) | n | 86 | 17 | – | 0.098b |
 | Median (Interquartile range) | 18 (12–26.5) | 13 (5.5–24) | ||
 | Range | 1–102 | 1–72 | ||
ADV total treatment time (months) | n | 115 | 30 | – | 0.939b |
 | Median (Interquartile range) | 60 (36–72) | 57 (38–69) | ||
 | Range | 5–144 | 9–132 | ||
ADV treatment time of pain onset (months) | n | 87 | 22 | – | 0.153b |
 | Median (Interquartile range) | 36 (24–48) | 47.5 (28–60) | ||
 | Range | 2–95 | 1–90 | ||
BMI (kg/m2) | n | 8 | 5 | 11 | 0.192a |
 | Mean ± SD | 21.21 ± 1.85 | 23.44 ± 3.98 | ||
 | Range | 19.53–24.70 | 18.00–28.00 | ||
Initial time of pain relief (months) | n | 76 | 20 | – | 0.003b |
 | Median (Interquartile range) | 1.5 (1–2) | 3 (2–6) | ||
 | Range | 0.3–6.0 | 0.5–18.0 | ||
Initial time of serum Phos. Rising (months) | n | 53 | 11 | – | 0.115b |
 | Median (Interquartile range) | 2 (1–3) | 3.5 (1.75–6) | ||
 | Range | 0.3–12.0 | 0.5–11.0 |